| Cured N. (%) | Surgery N. (%) | Embolic events N. (%) |
---|---|---|---|
MSSA N. 49 (79%) | 39/49 *(79.6%) | 16/49 ** (32.7%) | 33/49 *** (67.3%) |
MRSA N. 13 (21%) | 6/13 *(46.2%) | 4/13 ** (30.8%) | 7/13 *** (53.8%) |
Vancomycin tolerant N. 4/13 (30.8%) Vancomycin non tolerant N. 9/13 (69.2%) | 1/4 °(25,0%) 5/9 °(55,5%) |  |  |